CTI To Own Thermal Imaging Processor Outright Following Bales Acquisition
This article was originally published in The Gray Sheet
Computerized Thermal Imaging's acquisition of infrared imaging system manufacturer Bales Scientific includes Bales' thermal imaging processor, an adjunctive diagnostic tool that CTI already uses as part of its own thermal imaging system for breast cancer.
You may also be interested in...
Bales Scientific's website disclaimer that its infrared-emitting pain management system is not approved to treat specific medical conditions is not likely to be deemed acceptable by the FDA, agency staffers maintain, because the site goes on to describe conditions for which the system might be used.
Thermal Medical Imaging, Inc., will pursue a modular premarket approval application for the Thermal Breast Imaging System, the firm said April 15 in announcing FDA go-ahead to follow the modular PMA route.
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.